calendar
4,832 catalysts · 5,000 device 510k · 4,728 grant · 4,249 approval · 3,086 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
4,832 catalysts · 5,000 device 510k · 4,728 grant · 4,249 approval · 3,086 8k filing · 2,000 device pma · 2,000 device recall
no tagged catalysts yet
Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL
Sponsor: UCB INC. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: HIKMA. Form: TABLET. Route: ORAL
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
Sponsor: NOVO. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: PURACAP LABS BLU. Form: TABLET. Route: ORAL
Sponsor: PURACAP LABS BLU. Form: TABLET. Route: ORAL
Sponsor: ASTRAZENECA. Form: CAPSULE. Route: ORAL
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
Sponsor: BIOGEN US. Form: CAPSULE. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: GUERBET. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: AUROBINDO PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: ALKERMES INC. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: REGCON HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: REGCON HOLDINGS. Form: TABLET. Route: ORAL
Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: AMNEAL PHARMS NY. Form: TABLET. Route: ORAL
Sponsor: ORGANON USA LLC. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL
Sponsor: ACTELION. Form: TABLET. Route: ORAL
Sponsor: ACTELION. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: PAI HOLDINGS. Form: SOLUTION. Route: ORAL
Sponsor: PAI HOLDINGS. Form: SOLUTION. Route: ORAL